As per attachment.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company reported revenue from operations of ₹938.45 lakhs for Q2 FY26, up about 4% from ₹901.52 lakhs in Q2 FY25. For the half year (H1 FY26), revenue from operations grew nearly 20% to ₹1,885.82 lakhs versus ₹1,573.74 lakhs in H1 FY25, helped by an uptick in patient admissions and surgery volumes. Profit after tax rose modestly to ₹63.58 lakhs (H1 FY26) from ₹58.97 lakhs (H1 FY25), translating to EPS of ₹1.94 (basic). However, operating cash flow swung sharply negative to ₹(250.65) lakhs in H1 FY26, reflecting higher receivables and inventory build-up. EBITDA margin compressed to about 10.4% from 12.8% a year ago, and short-term borrowings jumped to ₹427.31 lakhs from ₹108.83 lakhs at March-end.
Revenue growth is decent but profit growth is lagging, margins are under pressure, and the company is burning cash from operations while taking on more short-term debt — a combination that may concern investors despite the topline improvement.